Ocugen, Inc. (OCGN)
1.79
+0.03
(+1.70%)
USD |
NASDAQ |
Apr 13, 16:00
1.785
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Investing (TTM) : -0.311M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| REGENXBIO, Inc. | -15.87M |
| Krystal Biotech, Inc. | -58.42M |
| Phathom Pharmaceuticals, Inc. | -0.229M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| MannKind Corp. | -304.80M |